These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 493865)

  • 1. Inhibition of gastric acid secretion by pirenzepine (LS 519) in man.
    Stockbrügger R; Jaup B; Hammer R; Dotevall G
    Scand J Gastroenterol; 1979; 14(5):615-20. PubMed ID: 493865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of pirenzepine on basal, pentagastrin- and insulin-stimulated gastric acid secretion in patients with peptic ulcer disease.
    Jaup BH; Stockbrügger R; Dotevall G
    Scand J Gastroenterol; 1979; 14(5):621-4. PubMed ID: 493866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of pentagastrin and insulin-stimulated gastric secretion by pirenzepine in healthy and duodenal ulcer subjects.
    Bianchi Porro G; Prada A; Petrillo M; Grossi M
    Scand J Gastroenterol Suppl; 1979; 57():63-7. PubMed ID: 396660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of pirenzepine and L-hyoscyamine on gastric emptying and salivary secretion in healthy volunteers.
    Jaup BH; Dotevall G
    Scand J Gastroenterol; 1981; 16(6):769-73. PubMed ID: 6119766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of various secretory inhibitors on peptic activity.
    Gabryelewicz A; Laszewicz W; Sarosiek J
    Scand J Gastroenterol Suppl; 1980; 66():79-85. PubMed ID: 6264587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inhibition of nocturnal acid secretion by pirenzepine (author's transl)].
    Dammann HG; Simon B; Müller P; Krüger HJ
    Arzneimittelforschung; 1982; 32(3):309-10. PubMed ID: 7044387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antisecretory activity of pirenzepine versus cimetidine in man: a controlled study.
    Procacciante F; Citone G; Montesani C; Ribotta G
    Gut; 1984 Feb; 25(2):178-82. PubMed ID: 6546371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of different doses of pirenzepine on gastric secretion stimulated by modified shamfeeding in man.
    Stockbrügger RW; Jaup BH; Dotevall G
    Scand J Gastroenterol Suppl; 1982; 72():111-7. PubMed ID: 6957978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of prolonged treatment of pirenzepine 2HCl on gastric secretion and plasma gastrin levels in rats.
    Okabe S; Tabata K; Kawakami M
    Arzneimittelforschung; 1982; 32(6):664-8. PubMed ID: 6896823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of pirenzepine (LS 519) on basal and pentagastrin-stimulated gastric acid secretion in normal persons].
    Galmiche JP; Lerebours E; Colin R
    Med Chir Dig; 1980; 9(4):331-4. PubMed ID: 6894012
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of cimetidine and pirenzepine on peroperative electrical vagal stimulation of gastric acid secretion.
    Fritsch WP; Schacht U; Scholten T; Hengels KJ; Mueller J; Strasser K
    Scand J Gastroenterol Suppl; 1980; 66():95-100. PubMed ID: 6941381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of intravenous pirenzepine on gastric acid and pepsin in man.
    el-Sabbagh HN; Prinz RA; Welbourn RB; Baron JH
    Scand J Gastroenterol Suppl; 1980; 66():73-7. PubMed ID: 6787694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effectiveness of cimetidine, pirenzepine and synthetic secretin on stimulated gastric acid secretion].
    Londong W; Londong V; Prechtl R; Schwanner A
    Z Gastroenterol; 1980 Jun; 18(6):306-13. PubMed ID: 6893378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of pirenzepine on basal gastric acid and pepsin secretion and on secretion stimulated with graded doses of pentagastrin in duodenal ulcer patients.
    Meneghelli UG; Troncon LE
    Braz J Med Biol Res; 1988; 21(4):781-9. PubMed ID: 3149202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of gastrin secretion by pirenzepine (LS 519) in treatment of gastric ulcer.
    Tatsuta M; Itoh T; Okuda S; Tamura H; Baba M; Yamamura H
    Scand J Gastroenterol; 1981; 16(2):269-71. PubMed ID: 6895560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response of basal and pentagastrin-stimulated gastric secretion and of serum gastrin to short- and long-term intravenous infusion of salmon calcitonin in hyperchlorhydric subjects.
    Paul F; Neumann F; Huchzermeyer H
    Scand J Gastroenterol; 1978; 13(8):959-67. PubMed ID: 569355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of a 100 mg pirenzepine--treatment on acid secretion and serum gastrin.
    Fritsch WP; Scholten T; Müller J; Hengels KJ; Hanrath KD
    Scand J Gastroenterol Suppl; 1982; 72():173-7. PubMed ID: 6957987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of cimetidine on pentagastrin-stimulated gastric secretion in healthy man.
    Aadland E; Berstad A; Semb LS
    Scand J Gastroenterol; 1977; 12(4):501-6. PubMed ID: 18791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of pentagastrin-stimulated and overnight gastric secretion by LM24056, a new phenothiazine-derived antisecretory drug.
    Boyd EJ; Wormsley KG
    Lancet; 1981 Feb; 1(8218):471-3. PubMed ID: 6110093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-ulcer and secretion-inhibitory properties of the tricyclic derivative doxepin in rats and dogs.
    Leitold M; Fleissig W; Merk A
    Arzneimittelforschung; 1984; 34(4):468-73. PubMed ID: 6547610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.